{"id":5524,"date":"2025-01-23T18:52:41","date_gmt":"2025-01-23T15:52:41","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=5524"},"modified":"2025-01-23T18:52:41","modified_gmt":"2025-01-23T15:52:41","slug":"comprehensive-summary-of-the-article-pet-ct-seeing-increasing-adoption-and-now-more-affordable-systems-have-facilities-taking-a-closer-look","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/comprehensive-summary-of-the-article-pet-ct-seeing-increasing-adoption-and-now-more-affordable-systems-have-facilities-taking-a-closer-look\/","title":{"rendered":"Comprehensive Summary of the Article: \u201cPET-CT Seeing Increasing Adoption, and Now More Affordable Systems Have Facilities Taking a Closer Look\u201d"},"content":{"rendered":"
Imaging ,January 2025.<\/div>\n
<\/div>\n
Comprehensive Summary of the Article: \u201cPET-CT Seeing Increasing Adoption, and Now More Affordable Systems Have Facilities Taking a Closer Look\u201d<\/div>\n
<\/div>\n
Increasing Adoption of PET-CT in Cardiology<\/div>\n
The American Society of Nuclear Cardiology (ASNC) reports growing adoption of positron emission tomography (PET) in nuclear cardiac imaging, with many experts predicting it could become the standard for nuclear cardiac assessments in the next decade. PET offers superior image quality compared to single photon emission computed tomography (SPECT), along with coronary flow reserve (CFR) quantification, which is valuable for evaluating microvascular disease. However, past barriers like high costs of radiotracers and technical limitations slowed its adoption.<\/div>\n
<\/div>\n
Advancements in PET-CT Technology<\/div>\n
Recent technological advancements have resolved prior issues:<\/div>\n
\u2022 Improved hybrid PET-CT systems with CT attenuation correction enable faster imaging and higher patient throughput.<\/span><\/div>\n
\u2022 New FDA-cleared radiotracers have become more widely available.<\/span><\/div>\n
\u2022 PET-CT systems now integrate CT-derived anatomical data, enhancing lesion evaluation and supporting decisions about revascularization strategies (e.g., PCI vs. bypass surgery).<\/span><\/div>\n
<\/div>\n
Comparison: Dedicated PET vs. PET-CT Systems<\/div>\n
\u2022 Dedicated PET systems handle 12 patients\/day, while PET-CT can manage 20+ exams\/day.<\/span><\/div>\n
\u2022 PET-CT systems enable opportunistic coronary calcium scoring, adding diagnostic value and potential revenue.<\/span><\/div>\n
<\/div>\n
Affordability and Innovation with Positron\u2019s NeuSight PET-CT<\/div>\n
Positron, a pioneer in PET technology, has launched the NeuSight PET-CT, which combines affordability with cutting-edge features:<\/div>\n
\u2022 Compact design, high sensitivity, and seamless integration with advanced diagnostic software.<\/span><\/div>\n
\u2022 Ideal for cardiovascular, oncological, and neurological applications.<\/span><\/div>\n
\u2022 Affordable pricing model includes rental options and all-inclusive support services.<\/span><\/div>\n
\u2022 Capable of significantly enhancing productivity, with throughput up to 200 scans\/month.<\/span><\/div>\n
<\/div>\n
Future Launch: Positron\u2019s Affinity 4D PET-CT<\/div>\n
Expected in mid-2025, the Affinity 4D system will introduce:<\/div>\n
\u2022 LYSO crystal technology for improved clarity and resolution.<\/span><\/div>\n
\u2022 AI-enhanced motion monitoring, respiratory gating, and advanced algorithms to reduce radiation and optimize workflows.<\/span><\/div>\n
<\/div>\n
Benefits of PET-CT Over SPECT<\/div>\n
PET-CT offers substantial advantages:<\/div>\n
\u2022 Higher image quality and diagnostic specificity.<\/span><\/div>\n
\u2022 Noninvasive coronary flow and myocardial flow reserve (MFR) analysis.<\/span><\/div>\n
\u2022 Improved evaluation of microvascular disease and ischemia with non-obstructive coronary arteries (INOCA).<\/span><\/div>\n
\u2022 Reduction in unnecessary diagnostic catheterizations.<\/span><\/div>\n
<\/div>\n
Clinical Impact and Success Stories<\/div>\n
Cardiologists and centers utilizing Positron systems have reported significant clinical and operational benefits:<\/div>\n
\u2022 At Niagara Falls Memorial Hospital, PET scans reduced chest pain-related mortality from 15% to below 4%.<\/span><\/div>\n
\u2022 PET imaging has proven valuable in managing patients, avoiding unnecessary invasive procedures, and identifying revascularization candidates.<\/span><\/div>\n
<\/div>\n
Outlook for PET-CT<\/div>\n
With its improved efficiency, affordability, and diagnostic capabilities, PET-CT systems like Positron\u2019s NeuSight and Affinity are poised to drive wider adoption. These systems address the increasing demand for high-quality imaging while maintaining cost-effectiveness, marking a transformative era in nuclear cardiac imaging.<\/div>\n
<\/div>\n
https:\/\/cardiovascularbusiness.us13.list-manage.com\/track\/click?u=ede357a4dde4e6d1363fede03&id=9e87c5df72&e=e8ff1dad3e<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Imaging ,January 2025. Comprehensive Summary of the Article: \u201cPET-CT Seeing Increasing Adoption, and Now More Affordable Systems Have Facilities Taking a Closer Look\u201d Increasing Adoption of PET-CT in Cardiology The American Society of Nuclear Cardiology (ASNC) reports growing adoption of positron emission tomography (PET) in nuclear cardiac imaging, with many experts predicting it could become […]<\/p>\n","protected":false},"author":1,"featured_media":5525,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5524","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5524","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=5524"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5524\/revisions"}],"predecessor-version":[{"id":5527,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/5524\/revisions\/5527"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media\/5525"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=5524"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=5524"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=5524"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}